Analysis of Orphan Drugs P&R criteria in Spain (2003-2019)

//Analysis of Orphan Drugs P&R criteria in Spain (2003-2019)

Analysis of Orphan Drugs P&R criteria in Spain (2003-2019)

Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019

Avaliable at: https://ojrd.biomedcentral.com/articles/10.1186/s13023-020-01507-4

2020-09-23T17:52:11+00:00August 28th, 2020|Articles|

Leave A Comment